ASBP Earnings Aspire Biopharma Holdings, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–6 of 6
| Q1 2026 | 2026-03-31 | -20.57 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -16.38 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -0.43 | 2025-11-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -504.88 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -1.90 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -0.02 | 2025-11-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.